Literature DB >> 15956545

Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Biswanath Majumder1, Michelle L Janket, Elizabeth A Schafer, Keri Schaubert, Xiao-Li Huang, June Kan-Mitchell, Charles R Rinaldo, Velpandi Ayyavoo.   

Abstract

Antigen presentation and T-cell activation are dynamic processes involving signaling molecules present in both APCs and T cells. Effective APC function and T-cell activation can be compromised by viral immune evasion strategies, including those of human immunodeficiency virus type 1 (HIV-1). In this study, we determined the effects of HIV-1 Vpr on one of the initial target of the virus, dendritic cells (DC), by investigating DC maturation, cytokine profiling, and CD8-specific T-cell stimulation function followed by a second signal. Vpr impaired the expression of CD80, CD83, and CD86 at the transcriptional level without altering normal cellular transcription. Cytokine profiling indicated that the presence of Vpr inhibited production of interleukin 12 (IL-12) and upregulated IL-10, whereas IL-6 and IL-1beta were unaltered. Furthermore, DC infected with HIV-1 vpr+ significantly reduced the activation of antigen-specific memory and recall cytotoxic-T-lymphocyte responses. Taken together, these results indicate that HIV-1 Vpr may in part be responsible for HIV-1 immune evasion by inhibiting the maturation of costimulatory molecules and cytokines essential for immune activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956545      PMCID: PMC1143734          DOI: 10.1128/JVI.79.13.7990-8003.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Viral subversion of the immune system.

Authors:  D Tortorella; B E Gewurz; M H Furman; D J Schust; H L Ploegh
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus.

Authors:  C Stahl-Hennig; R M Steinman; K Tenner-Racz; M Pope; N Stolte; K Mätz-Rensing; G Grobschupff; B Raschdorff; G Hunsmann; P Racz
Journal:  Science       Date:  1999-08-20       Impact factor: 47.728

3.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

4.  Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

Authors:  H Valdez; K Y Smith; A Landay; E Connick; D R Kuritzkes; H Kessler; L Fox; J Spritzler; J Roe; M B Lederman; H M Lederman; T G Evans; M Heath-Chiozzi; M M Lederman
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

5.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.

Authors:  S R Bartz; M A Vodicka
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

7.  Type 1 and type 2 cytokines in HIV infection -- a possible role in apoptosis and disease progression.

Authors:  M Clerici; M L Fusi; S Ruzzante; S Piconi; M Biasin; D Arienti; D Trabattoni; M L Villa
Journal:  Ann Med       Date:  1997-06       Impact factor: 4.709

8.  Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells.

Authors:  S A Stewart; B Poon; J B Jowett; Y Xie; I S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

9.  Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.

Authors:  P Brossart; M J Bevan
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

10.  Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells.

Authors:  I Grosjean; C Caux; C Bella; I Berger; F Wild; J Banchereau; D Kaiserlian
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  52 in total

1.  Accumulation of functionally immature myeloid dendritic cells in lymph nodes of rhesus macaques with acute pathogenic simian immunodeficiency virus infection.

Authors:  Viskam Wijewardana; Anthea L Bouwer; Kevin N Brown; Xiangdong Liu; Simon M Barratt-Boyes
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

2.  Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.

Authors:  Cynthia L Gay; Mark A DeBenedette; Irina Y Tcherepanova; Alicia Gamble; Whitney E Lewis; Anna B Cope; JoAnn D Kuruc; Kara S McGee; Mary F Kearney; John M Coffin; Nancie M Archin; Charles B Hicks; Joseph J Eron; Charles A Nicolette; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-21       Impact factor: 2.205

Review 3.  Natural regulatory T cells and persistent viral infection.

Authors:  Shuo Li; Eric J Gowans; Claire Chougnet; Magdalena Plebanski; Ulf Dittmer
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

4.  Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.

Authors:  Elizabeth D A Wheeler; Cristian L Achim; Velpandi Ayyavoo
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

5.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha.

Authors:  Biswanath Majumder; Narasimhan J Venkatachari; Elizabeth A Schafer; Michelle L Janket; Velpandi Ayyavoo
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

7.  Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Authors:  Pablo A González; Carolina E Prado; Eduardo D Leiva; Leandro J Carreño; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

8.  Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.

Authors:  Elizabeth A Miller; Meredith R Spadaccia; Meagan P OʼBrien; Linda Rolnitzky; Rachel Sabado; Olivier Manches; Davor Frleta; Nina Bhardwaj
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

9.  The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90.

Authors:  Irina Tcherepanova; Aijing Starr; Brad Lackford; Melissa D Adams; Jean-Pierre Routy; Mohamed Rachid Boulassel; David Calderhead; Don Healey; Charles Nicolette
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

10.  HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.

Authors:  Narasimhan J Venkatachari; Sean Alber; Simon C Watkins; Velpandi Ayyavoo
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.